Satraplatin - PDFSEARCH.IO - Document Search Engine

Satraplatin
Results: 6

#	Item
1	Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waivers under 18 U.S.C. §208(b)(3) and 21 U.S.C. $355 (n)(4) Otis Brawley, M.D. Commi.ttee: Add to Reading List Source URL: www.fda.gov Language: English - Date: 2007-07-09 08:23:18 GPC Biotech Spectrum Pharmaceuticals HRPC Satraplatin Prostate cancer
2	Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waiver under 21 U.S.C. 355(n)(4) Michael Perry, M.D. Committee: Oncologic Drugs Advisory Committee Add to Reading List Source URL: www.fda.gov Language: English - Date: 2007-07-09 08:23:20 Satraplatin Johnson Matthey Chemistry GPC Biotech HRPC
3	Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and a Waiver under 21 U.S.C. $355 (n)(4) Pamela Haylock, R.N., M.A. Committee: Add to Reading List Source URL: www.fda.gov Language: English - Date: 2007-07-09 08:23:20 HRPC Satraplatin GPC Biotech
4	Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waiver under 18 U.S .C. §208(b)(3) John T. Farrar, M.D. Committee: Add to Reading List Source URL: www.fda.gov Language: English - Date: 2007-07-09 08:23:19 HRPC Satraplatin GPC Biotech
5	Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate Shanta Dhara and Stephen J. Lipparda,b,1 aDepartment of Chemistry and bKoch Institute for Integrative Cancer Research, Massachusetts Institute Add to Reading List Source URL: www.thedcasite.com Language: English - Date: 2009-12-14 14:52:58 Alkylating antineoplastic agents Ammine complexes Apoptosis Cell signaling Cisplatin Dichloroacetic acid Warburg effect Carboplatin Satraplatin Biology Chemistry Programmed cell death
6	PDF Document Add to Reading List Source URL: clincancerres.aacrjournals.org Language: English Ammine complexes Eli Lilly and Company Carboplatin Cisplatin Prostate cancer Chemotherapy regimens Docetaxel Lung cancer Satraplatin Chemistry Medicine Alkylating antineoplastic agents

UPDATE